Elevance Health, Inc. ELV
- Market cap
- $86.4B
- P/E
- 17.6×
Follow ELV
Elevance Health, Inc. (ELV) Free cash flow
Elevance Health, Inc.'s free cash flow for fiscal 2025 was $3.2B, down 30.3% from $4.6B in fiscal 2024. Over the twelve months to 30 June 2026 it was $6.3B. Over the past ten years it has ranged from $2.6B (fiscal 2018) to $9.7B (fiscal 2020); the current reading is higher than 27% of that period. Free cash flow has fallen for 5 consecutive fiscal years. Elevance Health, Inc. ranks 5th of 12 Healthcare Plans companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $3.2B | (30.27%) |
| FY2024 | $4.6B | (32.71%) |
| FY2023 | $6.8B | (6.65%) |
| FY2022 | $7.2B | (0.41%) |
| FY2021 | $7.3B | (24.72%) |
| FY2020 | $9.7B | 93.96% |
| FY2019 | $5.0B | 90.30% |
| FY2018 | $2.6B | (22.83%) |
| FY2017 | $3.4B | 26.36% |
| FY2016 | $2.7B | (25.57%) |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $1.6B | (60.31%) |
| Mar 2026 | $4.1B | — |
| Dec 2025 | −$209.0M | — |
| Sep 2025 | $775.0M | (56.63%) |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $23.6B |
| CVS CVS Health Corporation compare | $11.8B |
| CI Cigna Group compare | $9.1B |
| CNC Centene Corporation compare | $9.0B |
| ELV Elevance Health, Inc. | $6.3B |
| OSCR Oscar Health, Inc. compare | $4.4B |
| HUM Humana Inc. compare | $2.0B |
| MOH Molina Healthcare, Inc compare | $271.0M |
| CLOV Clover Health Investments, Corp. compare | $74.2M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ELV
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement